|   LifeSciVC

Hotspot Therapeutics Turns Up The Heat On Natural Allostery

By Bruce Booth, DPhil, Partner

Most conventional small molecule drugs engage directly with the engine of a protein’s function, aiming to often turning off an enzymatic activity associated with a disease. These drugs bind and compete against the natural substrate of the protein at what are known as orthosteric sites. But other pockets on a protein can also modulate function, and these sites commonly referred to as allosteric sites.

Read more.